Opthea to Participate at the 2023 Euretina Congress - Opthea (NASDAQ:OPT) : vimarsana.com

MELBOURNE, Australia, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT, ASX:OPT)), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal

Related Keywords

Melbourne , Victoria , Australia , Amsterdam , Noord Holland , Netherlands , Megan Baldwin , Euretina Congress , Investment In Biotechnology Companies , Opthea Limited , Vitreous Society , Chief Executive Officer , Euretina Innovation Spotlight , Treatment Modalities , European Retina , Biotechnology Companies ,